Hypera acquires Sanofi brands in LatAm

Hypera acquires Sanofi brands in LatAm

M&A Healthcare Pharmaceuticals Brazil

Brazilian pharmaceutical company Hypera Pharma said Tuesday that it agreed to buy 12 brands of over-the-counter and prescription drugs in Brazil, Mexico and Colombia from France's Sanofi for $190 million. The deal includes mouth wash Cepacol, fever reducer AAS and herbal laxative Naturetti in the OTC segment along with prescription appetite stimulant Buclina and epilepsy medicine Hidantal, Hypera said in a securities filing.  The Brazilian market accounted for roughly 67% of net revenues from th

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial